$RCUS 4 SEC Filings

Filed On	Filing
24 Aug 2026	Form 4: Azoy Alexander, Chief Accounting Officer Received 2,827 shares by exercise or conversion ($43.6K) · Sold 2,827 shares ($84.8K)
13 Jul 2026	Form 4: Jaen Juan C., President Sold 48,502 shares ($1.46M) · Sold 20,067 shares ($574K)
24 Jun 2026	Form 4: Jaen Juan C., President Sold 9,236 shares ($250K) · Sold 15,764 shares ($437K) · Sold 6,431 shares ($191K)
12 Jun 2026	Form 4: Lambert Nicole, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Machado Patrick, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Kaneko Yasunori, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Tang Carolyn C., General Counsel Received 34,090 shares by exercise or conversion ($87.7K)
12 Jun 2026	Form 4: Lacey David L., Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Falberg Kathryn E, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Ribas Antoni, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Perlman Andrew J, Director Received 5,700 shares as a grant or award · Granted 16,900 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Azoy Alexander, Chief Accounting Officer Sold 2,562 shares ($66K)
12 May 2026	Form 4: Ribas Antoni, Director Gave 5,050 shares as a gift
12 May 2026	Form 4: Goeltz Ii Robert C., Chief Financial Officer Sold 7,763 shares ($199K)
26 Jan 2026	Form 4: Markus Richard, Chief Medical Officer Received 24,000 shares as a grant or award · Granted 96,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Rosen Terry J, Director Received 79,000 shares as a grant or award · Granted 315,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Jaen Juan C., President Received 31,000 shares as a grant or award · Granted 126,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Tang Carolyn C., General Counsel Received 24,000 shares as a grant or award · Granted 96,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Goeltz Ii Robert C., Chief Financial Officer Received 24,000 shares as a grant or award · Granted 96,000 Stock Option (right to buy)
26 Jan 2026	Form 4: Azoy Alexander, Chief Accounting Officer Received 21,050 shares as a grant or award · Granted 14,050 Stock Option (right to buy)

Comments